151 related articles for article (PubMed ID: 35733860)
1. Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus.
Yen CY; Yu SJ; Chen YM; Lai KL; Wu YD; Liao EC; Hsieh CL
Front Med (Lausanne); 2022; 9():870724. PubMed ID: 35733860
[TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
3. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
6. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
7. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
9. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
10. The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients.
Langer S; Langnickel D; Enghard P; Undeutsch R; Burmester GR; Hiepe F; Radbruch A; Riemekasten G
Rheumatology (Oxford); 2007 Feb; 46(2):238-45. PubMed ID: 16880187
[TBL] [Abstract][Full Text] [Related]
11. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
Tsao JT; Hsieh SC; Chiang BL; Yu CL; Lin SC
Clin Exp Med; 2012 Sep; 12(3):153-8. PubMed ID: 22057691
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response.
Lee JY; Park JK; Lee EY; Lee EB; Song YW
Arthritis Res Ther; 2016 Nov; 18(1):264. PubMed ID: 27852323
[TBL] [Abstract][Full Text] [Related]
13. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients.
Garcia-Rodriguez S; Callejas-Rubio JL; Ortego-Centeno N; Zumaquero E; Ríos-Fernandez R; Arias-Santiago S; Navarro P; Sancho J; Zubiaur M
Mediators Inflamm; 2012; 2012():495934. PubMed ID: 23125486
[TBL] [Abstract][Full Text] [Related]
14. [Cytokines in systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Robak T
Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan.
Lu LY; Cheng HH; Sung PK; Tai MH; Yeh JJ; Chen A
J Formos Med Assoc; 2005 Aug; 104(8):563-70. PubMed ID: 16193177
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.
Postal M; Ruocco HH; Brandão CO; Costallat LTL; Silva L; Cendes F; Appenzeller S
Neuroimmunomodulation; 2017; 24(2):100-105. PubMed ID: 28848179
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
[TBL] [Abstract][Full Text] [Related]
20. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
Saeed AM; Mogahed MM
Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
